News & Media
Stay up to date on our latest stories.
Sudair Pharma participated in the Saudi Heart Association Conference, showcasing its commitment to cardiovascular health through scientific engagement, community awareness, and a strategic MoU with the Saudi Heart Association to advance joint efforts in education and treatment.
- Exhibition
- 9 October 2025
Sudair Pharma announced that its Chief Executive Officer has been selected by Forbes Middle East as one of the Top Healthcare Leaders, recognizing his contribution to advancing Saudi pharmaceutical manufacturing and strengthening national healthcare capabilities.
- Media & Press Coverage
- 21 October 2025
Sudair Pharma participated in the Global Health Exhibition 2025, showcasing advanced national pharmaceutical capabilities and highlighting the company’s contribution to strengthening Saudi Arabia’s healthcare ecosystem. The SPC booth attracted significant interest and served as a platform for strategic discussions and industry engagement.
- Exhibition
- 27 October 2025
Sudair Pharma was honored to welcome His Excellency the Minister of Health, Fahad Al-Jalajel, during its participation in the Global Health Exhibition 2025. The visit highlighted the Kingdom’s commitment to strengthening national pharmaceutical manufacturing and advancing a sustainable healthcare system. Several senior officials and leaders also visited the booth, underscoring Sudair Pharma’s growing impact in shaping the future of Saudi healthcare.
- Exhibition
- 29 October 2025
Sudair Pharma signed two major agreements during the Global Health Exhibition 2025: a cooperation agreement with NUPCO to enhance the national pharmaceutical supply chain, and a localization agreement with the Local Content & Government Procurement Authority to manufacture Bilotinib locally. These agreements reinforce Sudair Pharma’s commitment to national self-sufficiency and Vision 2030 goals in pharmaceutical manufacturing.
- Local Content & Government Partnerships
- 30 October 2025